INHALATIONAL HYPNOTICS
IV HYPNOTICS
ANALGESICS
RECEPTORS
(Blank)
100

drug uptake,ventilation,agent concentration

Factors affecting alveolar concentration

100

Patient's failure to follow prescribed medication therapy.

Noncompliance/nonadherence/poor adherence

100

Elimination of medication from the body.

Excretion

100

Two drugs with similar actions sum their effects.

Additive effects

100

Ability of some drugs and chemicals to alter body cells and cause a variety of cancers.

Carcinogenicity

200

low volatile anesthetic B/G partition coefficient slows induction period   TRUE OR FALSE

FALSE

200

The amount of time required for serum concentration of a drug to decrease by 50%.

drug half-life

200

Passage of medication from administrative site to entry into the blood stream.

Absorption

200

Two drugs compete for the drug binding site on Albumin.

Displacement

200

Immune (antigen-antibody) response to a drug to which the patient was previously exposed and sensitized.

Allergy

300

decreasing rebreathing, high fresh gas flows, low anesthetic-circuit volume, low absorption by the anesthetic circuit, decreased solubility, high cerebral blood flow (CBF), and increased ventilation.

factors that speed up elimination and recovery

300

Psychological benefit from a compound that may not have the chemical substance of a drug effect.

Placebo Effects

300

Inactivation of medication preparation for excretion.

Metabolism/Biotransformation

300

Two drugs with different mechanisms of actions produce greater effects.

Synergism or Potentiation

300

Ability of some drugs, such as aminoglycoside antibiotics, to damage the renal tubule, causing renal insufficiency or failure.

 Nephrotoxicity

400

MAC decreases 10% per decade after the age of 40

TRUE/FALSE

FALSE

400

The process of drug movement to achieve drug action.

Pharmacokinetic

400

1) Condition of the kidneys, since most drugs are excreted in the urine. 2) Chemicals, foods, or other drugs that alter the pH of the urine.

Factors Affecting Excretion

400

Effects of two drugs that cancel each other. (Ex. 1+1=0 may be due to competition for binding sites on cell membranes)

Antagonism

400

drugs that damage the liver

hepatotoxicity

500

Occurs when the drug reaches its highest blood or plasma concentration.

Peak Action

500

Serum drug concentration within therapeutic range, dosage sufficient to be effective, but a peak serum concentration below the level of toxicity.

Therapeutic Index

500

1) Circulation, cardiac output, and blood supply to site of drug action. 2) Binding of drug to plasma protein albumin and tissue binding. 3) Level of plasma protein albumin. 4) For oral drugs, amount of drug metabolized in liver before reaching systemic circulation (first-pass phenomenon) 5) Blood-brain barrier prevents many drugs from entering central nervous system (CNS))

Factors Affecting Distribution

500

Physical interaction of two drugs that interferes with the effect of at least one of the drugs.

Incompatibility

500

Some drugs, especially those used to treat cancers, cause bone marrow depression, making patients susceptible to infection, anemia, and abnormal bleeding.

Hematologic effects

M
e
n
u